Aspira Women's Health amends securities purchase agreement; grants board seats, fixes warrant exercise price at $0.35

Aspira Women's Health Inc.

Amendment requires Aspira to file Form S-1 by Sept 30, 2025 to register shares and warrant shares.
Purchasers (existing accredited shareholders) gain right to appoint 3 directors until earlier of 3 years or 50% warrant threshold.
Warrants amended: fixed exercise price $0.35, cash-only exercise, 6-year term, exercisable after 6 months.
Exempt Issuance definition modified to exclude firm commitment or at-the-market offerings.

item 1.01item 3.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.